{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T10:59:07Z","timestamp":1786791547505,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2002,11]]},"DOI":"10.1124\/mol.62.5.1103","type":"journal-article","created":{"date-parts":[[2003,1,15]],"date-time":"2003-01-15T23:12:39Z","timestamp":1042672359000},"page":"1103-1111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Pharmacophore Definition and Three-Dimensional Quantitative Structure-Activity Relationship Study on Structurally Diverse Prostacyclin Receptor Agonists"],"prefix":"10.1016","volume":"62","author":[{"given":"Friederike","family":"Stoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Liesener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Hohlfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karsten","family":"Schr\u00f6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip L.","family":"Fuchs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Dieter","family":"H\u00f6ltje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.62.5.1103_bib1","first-page":"31","article-title":"3Dsearch and research using the Cambridge Structural Database.","volume":"8","author":"Allen","year":"1993","journal-title":"Chem Des Autom News"},{"key":"10.1124\/mol.62.5.1103_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0163-7258(96)00103-9","article-title":"Platelet prostanoid receptors.","volume":"72","author":"Armstrong","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1124\/mol.62.5.1103_bib3","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1476-5381.1986.tb10196.x","article-title":"Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.","volume":"87","author":"Armstrong","year":"1986","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.62.5.1103_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1124\/mol.51.1.61","article-title":"Substitution of charged amino acid residues in transmembrane regions 6 and 7 affect ligand binding and signal transduction of the prostaglandin EP3 receptor.","volume":"1997;51","author":"Audoly","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.62.5.1103_bib5","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors.","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci"},{"key":"10.1124\/mol.62.5.1103_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1023\/A:1007934413448","article-title":"IsoStar: a library of information about nonbonded interactions.","volume":"11","author":"Bruno","year":"1997","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/mol.62.5.1103_bib7","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1042\/bj3220597","article-title":"Functional interaction of the carboxylic acid group of agonists and the arginine residue of the seventh transmembrane domain of prostaglandin E receptor EP3 subtype.","volume":"322","author":"Chang","year":"1997","journal-title":"Biochem J"},{"key":"10.1124\/mol.62.5.1103_bib8","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/0040-4020(80)80168-2","article-title":"Iterative partial equalization of orbital electronegativity\u2014a rapid access to atomic charges.","volume":"36","author":"Gasteiger","year":"1980","journal-title":"Tetrahedron"},{"key":"10.1124\/mol.62.5.1103_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1021\/jm00145a002","article-title":"A computational procedure for determining energetically favorable binding sites on biologically important macromolecules.","volume":"28","author":"Goodford","year":"1985","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1042\/bj3070493","article-title":"Expression and site-directed mutagenesis of mouse prostaglandin E2 receptor EP3 subtype in insect cells.","volume":"307","author":"Huang","year":"1995","journal-title":"Biochem J"},{"key":"10.1124\/mol.62.5.1103_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0090-6980(94)90060-4","article-title":"Biochemical and pharmacological activity of arene-fused prostacyclin analogues on human platelets [published erratum appears in Prostaglandins 47:404].","volume":"47","author":"Jakubowski","year":"1994","journal-title":"Prostaglandins"},{"key":"10.1124\/mol.62.5.1103_bib12","first-page":"405","article-title":"Diphenylmethylazine prostanoids with prostacyclin-like actions on human platelets.","volume":"6","author":"Jones","year":"1993","journal-title":"J Lipid Mediat"},{"key":"10.1124\/mol.62.5.1103_bib13","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/BF00315517","article-title":"The action of Lovastatin on platelet function and platelet eicosanoid receptors in type II hypercholesterolemia.","volume":"45","author":"Kaczmarek","year":"1993","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/mol.62.5.1103_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1124\/mol.54.3.584","article-title":"A single amino-acid substitution in the EP2 prostaglandin receptor confers responsiveness to prostacyclin analogs.","volume":"54","author":"Kedzie","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/mol.62.5.1103_bib15","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1023\/A:1008027706830","article-title":"RigFit: a new approach to superimposing ligand molecules.","volume":"12","author":"Lemmen","year":"1998","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/mol.62.5.1103_bib16","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1023\/A:1007959729800","article-title":"Time-efficient flexible superposition of medium-sized molecules.","volume":"11","author":"Lemmen","year":"1997","journal-title":"J Comput Aided Mol Des"},{"key":"10.1124\/mol.62.5.1103_bib17","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1021\/jm981037l","article-title":"FLEXS: a method for fast flexible ligand superposition.","volume":"41","author":"Lemmen","year":"1998","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib18","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.1021\/jm00076a018","article-title":"Nonprostanoid prostacyclin mimetics. 5. Structure-activity relationships associated with [3-[4-(4, 5-diphenyl-2-oxazolyl)-5- oxazolyl]phenoxy]acetic acid.","volume":"36","author":"Meanwell","year":"1993","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib19","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1358\/dof.1994.019.04.595583","article-title":"Non-prostanoid prostacyclin mimetics.","volume":"19","author":"Meanwell","year":"1994","journal-title":"Drugs Future"},{"key":"10.1124\/mol.62.5.1103_bib20","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1021\/jm00097a007","article-title":"Nonprostanoid prostacyclin mimetics. 3. Structural variations of the diphenyl heterocycle moiety.","volume":"35","author":"Meanwell","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib21","first-page":"73","article-title":"Non-prostanoid prostacyclin mimetics. 6. Derivatives of 2-[3-[2-(4, 5-Diphenyl-2-oxazolyl)ethyl] phenoxy]acetic acid modified beta-to the oxazole ring.","volume":"11","author":"Meanwell","year":"1994","journal-title":"Drug Des Discov"},{"key":"10.1124\/mol.62.5.1103_bib22","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1021\/jm00097a006","article-title":"Nonprostanoid prostacyclin mimetics. 2. 4,5-Diphenyloxazole derivatives.","volume":"35","author":"Meanwell","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib23","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1021\/jm00076a017","article-title":"Nonprostanoid prostacyclin mimetics. 4. Derivatives of 2-[3-[2-(4,5-diphenyl-2-oxazolyl)ethyl]phenoxy]acetic acid substituted alpha to the oxazole ring.","volume":"36","author":"Meanwell","year":"1993","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1021\/jm00080a028","article-title":"Structure-activity relationships associated with 3,4, 5-triphenyl-1H-pyrazole-1-nonanoic acid, a nonprostanoid prostacyclin mimetic.","volume":"35","author":"Meanwell","year":"1992","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0223-5234(93)90092-S","article-title":"Thromboxane receptor active analogues based on the 6-oxabicyclo[3.2.1]octane ring system.","volume":"28","author":"Muir","year":"1993","journal-title":"Eur J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib26","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.1074\/jbc.270.27.16122","article-title":"Selective coupling of prostaglandin E receptor EP3D to Gi and Gs through interaction of alpha-carboxylic acid of agonist and arginine residue of seventh transmembrane domain.","volume":"270","author":"Negishi","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.62.5.1103_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.2610050102","article-title":"Prostacyclin-analogs.","volume":"5","author":"Nickolson","year":"1985","journal-title":"Med Res Rev"},{"key":"10.1124\/mol.62.5.1103_bib28","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1021\/jm9608016","article-title":"Smart region definition: a new way to improve the predictive ability and interpretability of three-dimensional quantitative structure-activity relationships.","volume":"40","author":"Pastor","year":"1997","journal-title":"J Med Chem"},{"key":"10.1124\/mol.62.5.1103_bib29","author":"Sippl","year":"1997","journal-title":"Molecular Modelling Studien zum Bindungsverhalten von Histamin H2- und H3-Rezeptor Liganden. Thesis, Heinrich-Heine-Universit\u00e4t D\u00fcsseldorf, Germany"},{"key":"10.1124\/mol.62.5.1103_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0166-1280(99)00361-9","article-title":"Structure-based 3D-QSAR\u2014merging the accuracy of structure-based alignments with the computational efficiency of ligand-based methods.","volume":"503","author":"Sippl","year":"2000","journal-title":"J Mol Struct (Theochem)"},{"key":"10.1124\/mol.62.5.1103_bib31","first-page":"299","article-title":"Synthesis of ciloprost (ZK 36 374): a chemically stable and biologically potent prostacyclin analog.","volume":"11","author":"Skuballa","year":"1983","journal-title":"Adv Prostaglandin Thromboxane Leukot Res"},{"key":"10.1124\/mol.62.5.1103_bib32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/0076-6879(82)86216-2","article-title":"Physical chemistry, stability and handling of prostaglandins E2, F2a, D2 and I2: a critical summary.","volume":"86","author":"Stehle","year":"1982","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.62.5.1103_bib33","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(98)00522-6","article-title":"A conserved threonine in the second extracellular loop of the human EP2 and EP4 receptors is required for ligand binding.","volume":"357","author":"Stillman","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/mol.62.5.1103_bib34","first-page":"131","article-title":"Structure-activity relationship between prostacyclin and its platelet receptor. Correlation of structure change and the platelet activity.","volume":"2","author":"Tsai","year":"1989","journal-title":"Eicosanoids"},{"key":"10.1124\/mol.62.5.1103_bib35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00129752","article-title":"Conformation of receptor-associated PGI2: an investigation by molecular modeling.","volume":"5","author":"Tsai","year":"1991","journal-title":"J Comput Aided Mol Des"}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24136929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24136929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.62.5.1103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T10:18:35Z","timestamp":1740046715000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24136929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["S0026895X24136929"],"URL":"https:\/\/doi.org\/10.1124\/mol.62.5.1103","relation":{},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacophore Definition and Three-Dimensional Quantitative Structure-Activity Relationship Study on Structurally Diverse Prostacyclin Receptor Agonists","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.62.5.1103","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2002 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}